BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22187043)

  • 1. Oral doxycycline for the treatment of chronic leg ulceration.
    Sadler GM; Wallace HJ; Stacey MC
    Arch Dermatol Res; 2012 Aug; 304(6):487-93. PubMed ID: 22187043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
    Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
    J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study.
    Preshaw PM; Grainger P; Bradshaw MH; Mohammad AR; Powala CV; Nolan A
    J Oral Pathol Med; 2007 Apr; 36(4):236-40. PubMed ID: 17391302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
    Gürkan A; Cinarcik S; Hüseyinov A
    J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.
    Mostow EN; Haraway GD; Dalsing M; Hodde JP; King D;
    J Vasc Surg; 2005 May; 41(5):837-43. PubMed ID: 15886669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lack of effect of oral zinc sulfate on wound healing in leg ulcer].
    Floersheim GL; Lais E
    Schweiz Med Wochenschr; 1980 Jul; 110(30):1138-45. PubMed ID: 7423160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative versus surgical treatment of venous leg ulcers: a prospective, randomized, multicenter trial.
    van Gent WB; Hop WC; van Praag MC; Mackaay AJ; de Boer EM; Wittens CH
    J Vasc Surg; 2006 Sep; 44(3):563-71. PubMed ID: 16950434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII in ulcerative leg disease: background and preliminary clinical results.
    Wozniak G; Dapper F; Alemany J
    Semin Thromb Hemost; 1996; 22(5):445-50. PubMed ID: 8989829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of healing and antimicrobiological effects of herbal therapy on venous leg ulcer: pilot study.
    Binić I; Janković A; Janković D; Janković I; Vrucinić Z
    Phytother Res; 2010 Feb; 24(2):277-82. PubMed ID: 19610037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline speeds up healing of chronic venous ulcers.
    Serra R; Gallelli L; Buffone G; Molinari V; Stillitano DM; Palmieri C; de Franciscis S
    Int Wound J; 2015 Apr; 12(2):179-84. PubMed ID: 23557025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers.
    Peschen M; Thimm C; Weyl A; Weiss JM; Kurz H; Augustin M; Simon JC; Schöpf E; Vanscheidt W
    Vasa; 1998 May; 27(2):89-93. PubMed ID: 9612112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study.
    Nayeri F; Strömberg T; Larsson M; Brudin L; Söderström C; Forsberg P
    J Dermatolog Treat; 2002 Jun; 13(2):81-6. PubMed ID: 12060507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency rhythmic electrical modulation system in the treatment of chronic painful leg ulcers.
    Janković A; Binić I
    Arch Dermatol Res; 2008 Aug; 300(7):377-83. PubMed ID: 18629524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
    Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
    Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline: a pilot study to reduce diabetic proteinuria.
    Naini AE; Harandi AA; Moghtaderi J; Bastani B; Amiran A
    Am J Nephrol; 2007; 27(3):269-73. PubMed ID: 17429196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.